From Fetal-maternal Interface Immune Tolerance to Endometrial Cancer Immune Escape: Potential Targets for Immunotherapy
Clinical trial NCT06273878 · UNKNOWN
Trial details
- NCT number
- NCT06273878
- Sponsor
- Regina Elena Cancer Institute
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2023-01-15
- Primary completion
- 2025-01-15
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.